20240032941. EMBOLIC MATERIAL DELIVERY DEVICE AND RELATED TECHNOLOGY simplified abstract (COVIDIEN LP)

From WikiPatents
Jump to navigation Jump to search

EMBOLIC MATERIAL DELIVERY DEVICE AND RELATED TECHNOLOGY

Organization Name

COVIDIEN LP

Inventor(s)

Jared Akira Shimizu of Tustin CA (US)

Junwei Li of Irvine CA (US)

Madeleine Roseen of Irvine CA (US)

Mehdi Matteo Rashidi of Irvine CA (US)

EMBOLIC MATERIAL DELIVERY DEVICE AND RELATED TECHNOLOGY - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240032941 titled 'EMBOLIC MATERIAL DELIVERY DEVICE AND RELATED TECHNOLOGY

Simplified Explanation

The abstract describes a device for treating intracranial aneurysms. The device includes a flexible conduit body with different flexibility zones and outer diameters. The second flexibility zone has a lower bending stiffness and outer diameter compared to the first flexibility zone. There is also a transition zone between the two flexibility zones that gradually changes the outer diameter.

  • The device is designed to treat intracranial aneurysms by delivering liquid embolic material to the affected area.
  • The conduit body of the device has different flexibility zones to accommodate the anatomy of the blood vessels in the brain.
  • The second flexibility zone has a lower bending stiffness and outer diameter, allowing for easier navigation through the blood vessels.
  • The transition zone helps in smoothly transitioning from the first flexibility zone to the second flexibility zone.
  • The device provides a more flexible and adaptable approach to treating intracranial aneurysms.

Potential Applications:

  • Treatment of intracranial aneurysms: The device can be used by medical professionals to treat patients with intracranial aneurysms by delivering liquid embolic material to the affected area.

Problems Solved:

  • Complex anatomy: The device addresses the challenge of navigating through the intricate blood vessels in the brain by providing different flexibility zones and a transition zone.
  • Treatment precision: The device allows for precise delivery of liquid embolic material to the aneurysm, ensuring effective treatment.

Benefits:

  • Improved treatment outcomes: The device's design enables better access to the aneurysm and more precise delivery of embolic material, leading to improved treatment outcomes.
  • Enhanced safety: The flexible nature of the device reduces the risk of vessel damage during the procedure.
  • Increased patient comfort: The device's adaptability to the blood vessel anatomy minimizes discomfort for the patient during the treatment process.


Original Abstract Submitted

a device for treating an intracranial aneurysm in accordance with an embodiment of the present technology includes an elongate conduit body defining an axial lumen through which the conduit body is configured to convey liquid embolic material toward the aneurysm. the conduit body includes a first flexibility zone defining a first average bending stiffness and a first outer diameter. the conduit body further includes a second flexibility zone distal to the first flexibility zone and defining a second average bending stiffness and a second outer diameter. the second average bending stiffness and the second outer diameter are less than the first average bending stiffness and the first outer diameter, respectively. the conduit body also includes a transition zone between the first and second flexibility zones. the transition zone defines a third outer diameter that transitions proximally-to-distally from the first outer diameter to the second outer diameter.